Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2009
08/20/2009WO2009071905A3 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases
08/20/2009WO2009059048A3 (+)-opioids and methods of use
08/20/2009WO2009046872A3 Use of a peptide as a therapeutic agent
08/20/2009WO2009033808A3 Use of a peptide as a therapeutic agent
08/20/2009WO2009033789A3 Use of a peptide as a therapeutic agent
08/20/2009WO2009033765A3 Use of a peptide as a therapeutic agent
08/20/2009WO2009033754A3 Use of a peptide as a therapeutic agent
08/20/2009WO2008124505A3 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
08/20/2009US20090209775 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
08/20/2009US20090209655 Isoflavone metabolites
08/20/2009US20090209631 Method for enhanced uptake of viral vectors in the myocardium
08/20/2009US20090209630 Vectors carrying coding sequences for angiogenic agents such as Del-1or VEGF formulated with poloxamers to improve bioavailability; avoids problems with toxicity inherent to existing delivery technologies; treating ischemia in a muscle, kidney or brain tissue
08/20/2009US20090209595 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209594 Method of treating of demyelinating diseases or conditions
08/20/2009US20090209585 Cycloalkene derivatives, process for production of the derivatives, and use of the same
08/20/2009US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof
08/20/2009US20090209562 Fused ring 4-oxopyrimidine derivative
08/20/2009US20090209559 Pharmaceutical compounds
08/20/2009US20090209556 Soluble guanylate cyclase activators
08/20/2009US20090209495 Use of edg receptor binding agents in cancer
08/20/2009US20090209469 Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass Composition
08/20/2009US20090208595 Extract of plant Dendrobii caulis and preparing process thereof
08/20/2009US20090208583 Tablets comprising candesartan cilexetil
08/20/2009US20090208573 Novel polymorph form of irbesartan
08/20/2009US20090208570 Extended Release Dosage forms of Metoprolol
08/20/2009US20090208555 Control of the degradation of biodegradable implants using a coating
08/20/2009US20090208507 Protein isoforms and uses thereof
08/20/2009US20090208499 adminstering N-(phosphonomethyl)-proline free of N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine to a patient to treat cosmetic conditions and medical disorders, symptoms or syndromes associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system
08/20/2009CA2747133A1 Uses of modified elr-cxc chemokine g31p
08/20/2009CA2718592A1 Method of treating vascular sclerosis
08/20/2009CA2714657A1 Anti-adam-15 antibodies and utilization of the same
08/20/2009CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009CA2714301A1 Use of ranolazine for the treatment of cardiovascular diseases
08/19/2009EP2090663A2 Method of preparing heart muscle cells and method of searching for remedy for heart diseases
08/19/2009EP2090589A1 Albumin-fused Kunitz domain peptides
08/19/2009EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
08/19/2009EP2090319A2 Angiotensin peptide-carrier conjugates and uses thereof
08/19/2009EP2090303A1 Association of a sinus current inhibitor if and a beta blocker
08/19/2009EP2090300A1 Sustained release preparation
08/19/2009EP2090177A1 Food products having enhanced cocoa polyphenol content
08/19/2009EP2089416A1 Depsipeptides and their therapeutic use
08/19/2009EP2089415A1 Depsipeptides and their therapeutic use
08/19/2009EP2089393A1 Heterocyclic compounds as antiinflammatory agents
08/19/2009EP2089367A1 Pyrazoline compounds as mineralocorticoid receptor antagonists
08/19/2009EP2089356A1 Salt of aliskiren with orotic acid
08/19/2009EP2089060A1 Liquid preparation comprising a complex of pimobendan and cyclodextrin
08/19/2009EP2089047A2 Compositions and methods for cardiac tissue protection and regeneration
08/19/2009EP2089026A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy
08/19/2009EP1915144A4 Method to reduce oxidative damage and improve mitochondrial efficiency
08/19/2009EP1838304B1 Heterocyclic aspartyl protease inhibitors
08/19/2009EP1691827B1 Use of peptides derived from the b beta chain of human fibronogen for the treatment of shock
08/19/2009EP1482973B1 Methods of modulating cd200 receptors
08/19/2009EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES
08/19/2009EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
08/19/2009EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/19/2009EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
08/19/2009CN101511852A Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs
08/19/2009CN101511833A 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists
08/19/2009CN101511828A Heteroaryl derivatives as protein kinase inhibitors
08/19/2009CN101511827A Pyridin-4-yl derivatives as immunomodulating agents
08/19/2009CN101511804A Cyclic sulfones useful as mitochondrial sodium-calcium exchangers
08/19/2009CN101511799A Cyclic amine compound
08/19/2009CN101511789A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
08/19/2009CN101511377A Lipid-metabolism-ameliorating agent
08/19/2009CN101511376A Cardiovascular preparation
08/19/2009CN101511369A Methods and compositions for inhibiting angiogenesis.
08/19/2009CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
08/19/2009CN101511365A Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
08/19/2009CN101508982A Deoxyribozyme for effective degradation of esoderma native-1mRNA and uses in reducing acute ischemic arrhythmia
08/19/2009CN101508722A Novel antihypertensive peptide and use thereof
08/19/2009CN101508719A 11-deoxidized biogastrone acid-3-0-succinic acid half-ester rare earth salt and synthesis thereof
08/19/2009CN101508696A 2-methyl-5-imidogen-benzo[d][1,3] oxazine[5-b] pyrazole compound, preparation method and application thereof
08/19/2009CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use
08/19/2009CN101508685A Improved preparation method for cinepazide maleate
08/19/2009CN101508684A Synthesis of cinepazide maleate
08/19/2009CN101508674A Benazepine-2-ketone compound containing ethylene imine ring, preparation and application thereof
08/19/2009CN101508672A Method of preparing 1,4-dihydrogen pyridine derivatives
08/19/2009CN101508652A Hyperpiesis resistant compound and method of preparing the same
08/19/2009CN101507810A Chinese patent medicine preparation capable of treating arrhythmia
08/19/2009CN101507798A Traditional Chinese medicine capable of chronic bronchitis and pulmonary heart disease
08/19/2009CN101507780A Sansheng medicine liquid capable of treating hemorrhoids
08/19/2009CN101507777A Medicine composite for treating coronary heart disease and preparation method thereof
08/19/2009CN101507765A Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof
08/19/2009CN101507756A Medicine for treating hemiplegia
08/19/2009CN101507749A Medicine composition for curing the cerebrovascular disease
08/19/2009CN101507747A Preparation method of astragalus total-saponin sodium chloride injector
08/19/2009CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof
08/19/2009CN101507738A Preparation method of Shu Xuening injection
08/19/2009CN101507729A Use of ginsenoside Compound K in preparing medicine capable of preventing and treating atherosclerosis
08/19/2009CN101507726A Association of a sinus If current inhibitor and a beta blocker
08/19/2009CN101507722A Combination for treating coronary heart disease angina
08/19/2009CN101507715A Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof
08/19/2009CN101507707A Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof
08/19/2009CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/19/2009CN100529753C Quality controlling method for pulse restoring injection
08/19/2009CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use
08/19/2009CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/19/2009CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
08/19/2009CN100528834C Pharmaceutical compounds
08/19/2009CN100528209C Preparation method of traditional Chinese medicine preparation having functions of invigorating qi and yin and blood and releasing poison
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 1595